Skip to search.
 FTSE 100 Down 2.71%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
6.00 Down 0.01(0.17%) 8 Feb 21:00
|After Hours: : 6.00 Up 0.00 (0.02%) 21:59
Prev Close:6.01
Open:5.99
Bid:4.75 x 1000
Ask:6.24 x 600
1y Target Est:20.20
Beta:2.39284
Earnings Date:14 Mar - 18 Mar (Est.)
Day's Range:5.75 - 6.07
52wk Range:4.50 - 10.83
Volume:2,244,041
Avg Vol (3m):1,760,970
Market Cap:433.10m
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INODown 0.17%433.10m
PFEDown 1.62%176.32b
AZNDown 4.46%72.53b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.40
Quarterly EPS Est (Dec-15) :-0.20
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback